Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
48.10
+3.21 (7.15%)
Nov 22, 2024, 4:00 PM EST - Market closed
Tectonic Therapeutic Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | - | -42.82 | -32.18 | -8.93 |
| Depreciation & Amortization | - | 1.48 | 1.01 | 0.36 |
| Other Amortization | - | - | - | 0.25 |
| Loss (Gain) From Sale of Assets | - | 0.01 | - | - |
| Stock-Based Compensation | - | 1.12 | 1.12 | 0.64 |
| Other Operating Activities | - | 0.12 | 0.58 | -6.7 |
| Change in Accounts Payable | - | -0.17 | -1.23 | 1.45 |
| Change in Other Net Operating Assets | - | -0.42 | 3.07 | 0.46 |
| Operating Cash Flow | - | -40.68 | -27.64 | -12.45 |
| Capital Expenditures | - | -0.28 | -2.09 | -2.12 |
| Investing Cash Flow | - | -0.28 | -2.09 | -2.12 |
| Long-Term Debt Issued | - | - | - | 4 |
| Long-Term Debt Repaid | - | -0.5 | -0.39 | -0.39 |
| Net Debt Issued (Repaid) | - | -0.5 | -0.39 | 3.61 |
| Issuance of Common Stock | - | 34.25 | 0 | 0 |
| Financing Cash Flow | - | 33.75 | 37.63 | 41.42 |
| Foreign Exchange Rate Adjustments | - | 0.02 | - | - |
| Net Cash Flow | - | -7.2 | 7.9 | 26.84 |
| Free Cash Flow | - | -40.96 | -29.73 | -14.58 |
| Free Cash Flow Per Share | - | -15.55 | -11.77 | - |
| Levered Free Cash Flow | - | 5.96 | -18.46 | - |
| Unlevered Free Cash Flow | - | 6.05 | -18.37 | - |
| Change in Net Working Capital | - | -31.64 | -2.11 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.